COR

Cencora Inc. Price

Closed
COR
$330.23
+$0.28(+0.08%)

*Data last updated: 2026-10-31 19:06 (UTC+8)

As of 2026-10-31 19:06, Cencora Inc. (COR) is priced at $330.23, with a total market cap of $63.13B, a P/E ratio of 38.96, and a dividend yield of 0.72%. Today, the stock price fluctuated between $329.71 and $339.40. The current price is 0.15% above the day's low and 2.70% below the day's high, with a trading volume of 1.34M. Over the past 52 weeks, COR has traded between $244.98 to $345.36, and the current price is -4.38% away from the 52-week high.

Key Stats

Yesterday's Close$330.53
Market Cap$63.13B
Volume1.34M
P/E Ratio38.96
Dividend Yield (TTM)0.72%
Diluted EPS (TTM)13.58
Net Income (FY)$0.00
Revenue (FY)$0.00
Earnings Date2026-11-04
EPS Estimate4.58
Revenue Estimate$87.95B
Shares Outstanding191M
Beta (1Y)0.581

Introduction

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
SectorHealthcare
IndustryMedical - Distribution
CEORobert Mauch
HeadquartersConshohocken,PA,US
Official Websitehttps://www.cencora.com
Employees (FY)47.00K

Learn

Gate Learn Articles

Gate TradFi Stock Section Launches 44 New CFD Trading Pairs, Unveils New Listings Trading Competition with 100,000 USDT Prize PoolGate TradFi will host the Commodity × Stock New Token Trading Competition from March 25 at 12:00 to April 8 at 12:00 (UTC+8).2026-03-24
TradFi Commodities × Stock Zone Launch: Trade global hard assets and split 100,000 USDTGate TradFi introduces new tokens. The Commodity × Stock Zone New Token Trading Competition is underway, offering a generous 100,000 USDT prize pool ready to be claimed.2026-03-24
What is Moonshot? All You Need To Know About MoonshotMoonshot is a mobile app focused on discovering, buying, and selling memecoins, with support for fiat on-ramp options and an interface designed to simplify on-chain trading. Moonshot is mainly associated with the Solana memecoin market and presents itself as a consumer app for tracking trends, accessing new tokens, and managing trades in one place. ## What is Moonshot? Moonshot is a mobile app for discovering, funding, buying, and selling memecoins through a more streamlined workflow than a traditional wallet-plus-DEX path. For anyone asking “what is Moonshot,” the simplest answer is that it is a consumer-facing trading app that combines token discovery, fiat onboarding, wallet-style access, and trade execution in one place. In practical terms, Moonshot tries to shorten the path between seeing a trending token and actually buying it. That makes it relevant to users who care about speed, convenience, and reduced setup friction in the Solana memecoin market. At the same time, Moonshot does not remove the cor2026-10-21

COR FAQ

What's the stock price of Cencora Inc. (COR) today?

x
Cencora Inc. (COR) is currently trading at $330.23, with a 24h change of +0.08%. The 52-week trading range is $244.98–$345.36.

What are the 52-week high and low prices for Cencora Inc. (COR)?

x

What is the price-to-earnings (P/E) ratio of Cencora Inc. (COR)? What does it indicate?

x

What is the market cap of Cencora Inc. (COR)?

x

What is the most recent quarterly earnings per share (EPS) for Cencora Inc. (COR)?

x

Should you buy or sell Cencora Inc. (COR) now?

x

What factors can affect the stock price of Cencora Inc. (COR)?

x

How to buy Cencora Inc. (COR) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.